{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:34:34Z","timestamp":1792510474312,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"am","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007197","name":"Public Health Service","doi-asserted-by":"publisher","award":["NIH P01 AI057788"],"award-info":[{"award-number":["NIH P01 AI057788"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"Public Health Service","doi-asserted-by":"publisher","award":["T32 AI055413"],"award-info":[{"award-number":["T32 AI055413"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"Public Health Service","doi-asserted-by":"publisher","award":["NIH P30 DK56338"],"award-info":[{"award-number":["NIH P30 DK56338"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"US Department of Agriculture, National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2011-68003-30395"],"award-info":[{"award-number":["2011-68003-30395"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006988","name":"John S. Dunn Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006988","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.clinthera.2017.07.002","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T20:45:17Z","timestamp":1501101917000},"page":"1537-1549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Prospects and Challenges in the Development of a Norovirus Vaccine"],"prefix":"10.1016","volume":"39","author":[{"given":"Nicolas W.","family":"Cortes-Penfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasirekha","family":"Ramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Estes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Atmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2017.07.002_bib1","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3201\/eid1908.130465","article-title":"Norovirus disease in the United States","volume":"19","author":"Hall","year":"2013","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/JCM.02680-13","article-title":"Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013","volume":"52","author":"Vega","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMsa1206589","article-title":"Norovirus and medically attended gastroenteritis in U.S. children","volume":"368","author":"Payne","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2017.07.002_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jpids\/pis070","article-title":"Noroviruses: The Most Common Pediatric Viral Enteric Pathogen at a Large University Hospital After Introduction of Rotavirus Vaccination","volume":"2","author":"Koo","year":"2013","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.clinthera.2017.07.002_bib5","doi-asserted-by":"crossref","first-page":"e0151219","DOI":"10.1371\/journal.pone.0151219","article-title":"Global Economic Burden of Norovirus Gastroenteritis","volume":"11","author":"Bartsch","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinthera.2017.07.002_bib6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1473-3099(14)70767-4","article-title":"Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis","volume":"14","author":"Ahmed","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib7","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1016\/j.vaccine.2012.09.040","article-title":"The potential economic value of a human norovirus vaccine for the United States","volume":"30","author":"Bartsch","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2017.07.002_bib8","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1016\/j.vaccine.2014.07.070","article-title":"Relative cost-effectiveness of a norovirus vaccine in the deployed military setting compared to a vaccine against Campylobacter sp., ETEC, and Shigella sp","volume":"32","author":"Tallant","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2017.07.002_bib9","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00705-013-1708-5","article-title":"Proposal for a unified norovirus nomenclature and genotyping","volume":"158","author":"Kroneman","year":"2013","journal-title":"Arch Virol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib10","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1128\/CVI.00015-15","article-title":"Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition","volume":"22","author":"Malm","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib11","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/infdis\/jiu361","article-title":"High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children","volume":"210","author":"Malm","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib12","doi-asserted-by":"crossref","first-page":"e1002705","DOI":"10.1371\/journal.ppat.1002705","article-title":"Immunogenetic mechanisms driving norovirus GII.4 antigenic variation","volume":"8","author":"Lindesmith","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.clinthera.2017.07.002_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00567-17","article-title":"Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades","volume":"91","author":"Sharma","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/CVI.00516-14","article-title":"Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity","volume":"22","author":"Czak\u00f3","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/0470846534.ch11","article-title":"The molecular biology of human caliciviruses","volume":"238","author":"Clarke","year":"2001","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.clinthera.2017.07.002_bib16","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1128\/JVI.78.12.6469-6479.2004","article-title":"Inter- and intragenus structural variations in caliciviruses and their functional implications","volume":"78","author":"Chen","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib17","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/jcm.31.8.2185-2191.1993","article-title":"Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations","volume":"31","author":"Green","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib18","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1128\/jvi.66.11.6527-6532.1992","article-title":"Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein","volume":"66","author":"Jiang","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib19","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1128\/JVI.72.2.1345-1353.1998","article-title":"Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice","volume":"72","author":"Ball","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib20","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1128\/JVI.75.20.9713-9722.2001","article-title":"Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses","volume":"75","author":"Guerrero","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib21","doi-asserted-by":"crossref","first-page":"14017","DOI":"10.1128\/JVI.79.22.14017-14030.2005","article-title":"The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors","volume":"79","author":"Tan","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib22","doi-asserted-by":"crossref","first-page":"e1005334","DOI":"10.1371\/journal.ppat.1005334","article-title":"Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go?","volume":"12","author":"Ramani","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.clinthera.2017.07.002_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM197707142970204","article-title":"Clinical immunity in acute gastroenteritis caused by Norwalk agent","volume":"297","author":"Parrino","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2017.07.002_bib24","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3201\/eid1908.130472","article-title":"Duration of immunity to norovirus gastroenteritis","volume":"19","author":"Simmons","year":"2013","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib25","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.aaf5211","article-title":"Replication of human noroviruses in stem cell-derived human enteroids","volume":"353","author":"Ettayebi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.clinthera.2017.07.002_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/19490976.2015.1052211","article-title":"Identification of a novel cellular target and a co-factor for norovirus infection - B cells & commensal bacteria","volume":"6","author":"Karst","year":"2015","journal-title":"Gut Microbes"},{"key":"10.1016\/j.clinthera.2017.07.002_bib27","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1038\/nprot.2015.121","article-title":"Human norovirus culture in B cells","volume":"10","author":"Jones","year":"2015","journal-title":"Nat Protoc"},{"key":"10.1016\/j.clinthera.2017.07.002_bib28","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/cid\/cis238","article-title":"Nomenclature for immune correlates of protection after vaccination","volume":"54","author":"Plotkin","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/infdis\/161.1.18","article-title":"Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults","volume":"161","author":"Johnson","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/infdis\/151.1.99","article-title":"Evidence of immunity induced by naturally acquired rotavirus and Norwalk virus infection on two remote Panamanian islands","volume":"151","author":"Ryder","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib31","doi-asserted-by":"crossref","first-page":"9718","DOI":"10.1128\/JVI.01570-14","article-title":"Newcastle disease virus vector producing human norovirus-like particles induces serum, cellular, and mucosal immune responses in mice","volume":"88","author":"Kim","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib32","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/656364","article-title":"Serological correlate of protection against norovirus-induced gastroenteritis","volume":"202","author":"Reeck","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib33","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/CVI.05592-11","article-title":"Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus","volume":"19","author":"Czak\u00f3","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib34","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","article-title":"Norovirus vaccine against experimental human Norwalk Virus illness","volume":"365","author":"Atmar","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2017.07.002_bib35","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/infdis\/jir661","article-title":"Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection","volume":"204","author":"Ohmit","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/infdis\/jiv053","article-title":"Mucosal and Cellular Immune Responses to Norwalk Virus","volume":"212","author":"Ramani","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/infdis\/129.6.709","article-title":"Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers","volume":"129","author":"Wyatt","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib38","doi-asserted-by":"crossref","first-page":"e1001807","DOI":"10.1371\/journal.pmed.1001807","article-title":"Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial","volume":"12","author":"Lindesmith","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.clinthera.2017.07.002_bib39","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/INF.0b013e3181a4bb60","article-title":"Symptomatic and asymptomatic rotavirus and norovirus infections during infancy in a Chilean birth cohort","volume":"28","author":"O\u2019Ryan","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2017.07.002_bib40","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00431-015-2591-8","article-title":"Multiple consecutive norovirus infections in the first 2 years of life","volume":"174","author":"Blazevic","year":"2015","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clinthera.2017.07.002_bib41","doi-asserted-by":"crossref","first-page":"e0157007","DOI":"10.1371\/journal.pone.0157007","article-title":"Norovirus Gastroenteritis in a Birth Cohort in Southern India","volume":"11","author":"Menon","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinthera.2017.07.002_bib42","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1016\/j.vaccine.2011.08.026","article-title":"Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis","volume":"29","author":"Blazevic","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2017.07.002_bib43","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.vaccine.2007.11.039","article-title":"Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice","volume":"26","author":"Guo","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2017.07.002_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.virol.2008.08.047","article-title":"Noroviral P particle: structure, function and applications in virus-host interaction","volume":"382","author":"Tan","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.clinthera.2017.07.002_bib45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0016-5085(99)70548-2","article-title":"Recombinant Norwalk virus-like particles given orally to volunteers: phase I study","volume":"117","author":"Ball","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2017.07.002_bib46","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1086\/657087","article-title":"Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues","volume":"202","author":"El-Kamary","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.clim.2012.05.006","article-title":"Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers","volume":"144","author":"Ramirez","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib48","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1016\/j.vaccine.2012.03.050","article-title":"Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations","volume":"30","author":"Parra","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2017.07.002_bib49","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/infdis\/jiu337","article-title":"A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults","volume":"210","author":"Treanor","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib50","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.vaccine.2014.09.073","article-title":"Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine","volume":"33","author":"Sundararajan","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2017.07.002_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00571-16","article-title":"B-Cell Responses to Intramuscular Administration of a Bivalent Virus-like Particle Human Norovirus Vaccine","volume":"24","author":"Ramani","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib52","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/infdis\/jiu497","article-title":"Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults","volume":"211","author":"Bernstein","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib53","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/infdis\/jiw259","article-title":"Rapid Responses to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: A Randomized Controlled Trial","volume":"214","author":"Atmar","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib54","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1016\/j.vaccine.2009.06.065","article-title":"A recombinant adenovirus prime-virus-like particle boost regimen elicits effective and specific immunities against norovirus in mice","volume":"27","author":"Guo","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2017.07.002_bib55","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S1473-3099(15)00266-2","article-title":"High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial","volume":"15","author":"Liebowitz","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib56","year":"2017","journal-title":"Vaxart Announces Positive Phase 1 Study of Oral Norovirus Vaccine"},{"key":"10.1016\/j.clinthera.2017.07.002_bib57","doi-asserted-by":"crossref","first-page":"e70409","DOI":"10.1371\/journal.pone.0070409","article-title":"Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice","volume":"8","author":"Tamminen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinthera.2017.07.002_bib58","doi-asserted-by":"crossref","first-page":"9171632","DOI":"10.1155\/2016\/9171632","article-title":"Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles","volume":"2016","author":"Malm","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.clinthera.2017.07.002_bib59","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/JVI.01835-10","article-title":"Norovirus P particle, a novel platform for vaccine development and antibody production","volume":"85","author":"Tan","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib60","doi-asserted-by":"crossref","first-page":"7670","DOI":"10.1016\/j.vaccine.2011.07.139","article-title":"A candidate dual vaccine against influenza and noroviruses","volume":"29","author":"Xia","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2017.07.002_bib61","doi-asserted-by":"crossref","first-page":"e0171174","DOI":"10.1371\/journal.pone.0171174","article-title":"Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens","volume":"12","author":"Elaish","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinthera.2017.07.002_bib62","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.vaccine.2013.11.064","article-title":"A dual vaccine candidate against norovirus and hepatitis E virus","volume":"32","author":"Wang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2017.07.002_bib63","doi-asserted-by":"crossref","first-page":"9728","DOI":"10.1128\/JVI.01249-14","article-title":"Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs","volume":"88","author":"Kocher","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib64","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/JVI.76.2.730-742.2002","article-title":"Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles","volume":"76","author":"Harrington","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib65","doi-asserted-by":"crossref","first-page":"807539","DOI":"10.1155\/2014\/807539","article-title":"Norovirus Narita 104 virus-like particles expressed in Nicotiana benthamiana induce serum and mucosal immune responses","volume":"2014","author":"Mathew","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.clinthera.2017.07.002_bib66","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.vaccine.2008.01.053","article-title":"An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles","volume":"26","author":"Santi","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2017.07.002_bib67","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1467-7652.2006.00191.x","article-title":"Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein","volume":"4","author":"Zhang","year":"2006","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.clinthera.2017.07.002_bib68","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jmv.20762","article-title":"Norovirus capsid protein expressed in yeast forms virus-like particles and stimulates systemic and mucosal immunity in mice following an oral administration of raw yeast extracts","volume":"79","author":"Xia","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib69","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1128\/CVI.00230-10","article-title":"An intranasally delivered Toll-like receptor 7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles","volume":"17","author":"Velasquez","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.clinthera.2017.07.002_bib70","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/315653","article-title":"Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes","volume":"182","author":"Tacket","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2017.07.002_bib71","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1016\/j.vaccine.2011.05.027","article-title":"Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine","volume":"29","author":"Velasquez","year":"2011","journal-title":"Vaccine"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817307695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817307695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:49:40Z","timestamp":1758962980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291817307695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":71,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0149291817307695"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.07.002","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospects and Challenges in the Development of a Norovirus Vaccine","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}